GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 08, 2025 |
PDB ID | UniProt ID | Title ▼ | Descriptor |
---|---|---|---|
7X7T | 7X7T | Cryo-EM structure of SARS-CoV-2 spike protein in complex with three nAbs X01, X10 and X17 | |
7X7T | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with three nAbs X01, X10 and X17 | |
7XRP | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement) | |
7XRP | 7XRP | Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement) | |
8IVA | 8IVA | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs XMA01 and 3E2 (local refinement) | |
8IVA | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs XMA01 and 3E2 (local refinement) | |
8IV4 | 8IV4 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 3E2 (local refinement) | |
8IV4 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 3E2 (local refinement) | |
8IV5 | 8IV5 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 1C4 (local refinement) | |
8IV5 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 1C4 (local refinement) | |
8IV8 | 8IV8 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 3E2 and 1C4 (local refinement) | |
8IV8 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 3E2 and 1C4 (local refinement) | |
7RQ6 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isolated from convalescent individual | |
7RQ6 | 7RQ6 | Cryo-EM structure of SARS-CoV-2 spike in complex with non-neutralizing NTD-directed CV3-13 Fab isolated from convalescent individual | |
7MM0 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7MM0 | 7MM0 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7MLZ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7MLZ | 7MLZ | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody B1-182.1 that targets the receptor-binding domain | |
7LRT | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LRT | 7LRT | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LRS | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7LRS | 7LRS | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
7TB8 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1 | |
7TB8 | 7TB8 | Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1 | |
7EJ5 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45 | |
7EJ5 | 7EJ5 | Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-45 | |
7EJ4 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25 | |
7EJ4 | 7EJ4 | Cryo-EM structure of SARS-CoV-2 spike in complex with a neutralizing antibody RBD-chAb-25 | |
7XY4 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with VHH21 | |
7XY4 | 7XY4 | Cryo-EM structure of SARS-CoV-2 spike in complex with VHH21 | |
7XY3 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with VHH14 | |
7XY3 | 7XY3 | Cryo-EM structure of SARS-CoV-2 spike in complex with VHH14 | |
7YC5 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with K202.B bispecific antibody | |
7YC5 | 7YC5 | Cryo-EM structure of SARS-CoV-2 spike in complex with K202.B bispecific antibody | |
7TYZ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with FSR22, an anti-SARS-CoV-2 DARPin | |
7TYZ | 7TYZ | Cryo-EM structure of SARS-CoV-2 spike in complex with FSR22, an anti-SARS-CoV-2 DARPin | |
7XMX | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three F61 Fab | |
7XMX | 7XMX | Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three F61 Fab | |
7XMZ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three D2 Fab | |
7XMZ | 7XMZ | Cryo-EM structure of SARS-CoV-2 spike glycoprotein in complex with three D2 Fab | |
8BGG | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD) | |
8BGG | 8BGG | Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD) | |
8BEV | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD) | |
8BEV | 8BEV | Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD) | |
7WP8 | 7WP8 | Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK1628x in complex with three neutralizing antibodies | |
7WP8 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK1628x in complex with three neutralizing antibodies | |
7WP6 | 7WP6 | Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK in complex with three neutralizing antibodies | |
7WP6 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 recombinant spike protein STFK in complex with three neutralizing antibodies | |
8WPY | 8WPY | Cryo-EM structure of SARS-CoV-2 receptor-binding domain (RBD) complexed with CB6 mutant,S309, and S304 antibodies | |
8WPY | P0DTC2 | Cryo-EM structure of SARS-CoV-2 receptor-binding domain (RBD) complexed with CB6 mutant,S309, and S304 antibodies |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024